ZGS-74384-91505
4 vaccinations
14 coded responses
53 check-ins
13 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 875 / NM
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 1 — Pfizer-BioNTech
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-12
-
2021-03-17
Survey response — day 14, dose 1MedDRA: Fatigue, Headache — Feeling: GoodFree text: A lot of fatigue and vague headachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Dose 2 — Pfizer-BioNTech
-
2021-03-24
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Very light-headedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — days 1–6 daily, dose 2MedDRA: Cheilitis — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: A sore appeared on my lipMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Survey response — days 1–6 daily, dose 2MedDRA: Cheilitis — Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Still have a sore on my lipMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-27
Survey response — days 1–6 daily, dose 2MedDRA: Cheilitis — Feeling: Good · Site: Pain, RednessFree text: Sore on my lip is nearly goneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Survey response — days 1–6 daily, dose 2MedDRA: Cheilitis — Feeling: GoodFree text: Sore on lip almost goneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Survey response — days 1–6 daily, dose 2MedDRA: Cheilitis — Feeling: GoodFree text: Still very small sore on lip. 99% goneMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
-
2021-04-28
Survey response — day 35, dose 2MedDRA: Fatigue — Feeling: FairFree text: Continued increasing fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-05
- 2021-06-23
- 2021-09-22
-
2021-10-09
Dose 3 — Pfizer-BioNTech
- 2021-10-11
- 2021-10-12
- 2021-10-13
- 2021-10-14
-
2021-10-15
Survey response — days 1–6 daily, dose 3MedDRA: Nasal congestion — Feeling: Fair · HeadacheFree text: Stuffy noseMedDRA releases: 2024-11 · check-in free text available
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2021-11-20
-
2022-01-08
Survey response — 3 months, dose 3MedDRA: Eye pruritus, Headache, Lacrimation increased, Nasal congestion, Oropharyngeal pain — Feeling: Good · Be unable to do your normal daily activitiesFree text: Stuffy nose, headache, sore throat, itchy and watery eyesMedDRA releases: 2024-11 · check-in free text available
-
2022-04-09
Survey response — 6 months, dose 3MedDRA: Fatigue, Headache, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue, congestion, headachesMedDRA releases: 2024-11 · check-in free text available
-
2022-04-23
Dose 4 — Pfizer-BioNTech
-
2022-04-23
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-24
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-25
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2022-04-26
- 2022-04-27
- 2022-04-28
- 2022-04-29
- 2022-04-30
- 2022-05-07
- 2022-05-14
- 2022-05-21
- 2022-05-28
- 2022-06-04
-
2022-07-23
Survey response — 3 months, dose 4MedDRA: Fatigue, Headache, Insomnia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Fatigue, sleeplessness, mild headachesMedDRA releases: 2024-11 · check-in free text available
-
2022-10-22
Survey response — 6 months, dose 4MedDRA: Dizziness, Headache, Pyrexia, Vertigo — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Vertigo, dizziness, headaches and intermittent feverMedDRA releases: 2024-11 · check-in free text available
-
2023-04-23
Survey response — 12 months, dose 4MedDRA: Influenza like illness — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech | |
| 3 | 2021-10-09 | Pfizer-BioNTech | No |
| 4 | 2022-04-23 | Pfizer-BioNTech | No |
Free text
Release 5 — day 14, dose 1
Symptoms: A lot of fatigue and vague headaches
Release 6 — day 0, dose 2
Systemic reaction (other): Very light-headed
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): A sore appeared on my lip
Systemic reaction (other): Still have a sore on my lip
Systemic reaction (other): Sore on my lip is nearly gone
Systemic reaction (other): Sore on lip almost gone
Systemic reaction (other): Still very small sore on lip. 99% gone
Release 8 — day 35, dose 2
Symptoms: Continued increasing fatigue
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Stuffy nose
Release 10 — 3 months, dose 3
Symptoms: Stuffy nose, headache, sore throat, itchy and watery eyes
Release 11 — 6 months, dose 3
Symptoms: Fatigue, congestion, headaches
Release 12 — 3 months, dose 4
Symptoms: Fatigue, sleeplessness, mild headaches
Release 12 — 6 months, dose 4
Symptoms: Vertigo, dizziness, headaches and intermittent fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dizziness | · | · | ✓ |
| SD | Eye pruritus | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SRO | Cheilitis | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release